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Previous studies have shown that oesophageal and gastric cancers are the most common causes of cancer death in the Golestan
Province, Iran. In 2001, we established Atrak Clinic, a referral clinic for gastrointestinal (GI) diseases in Gonbad, the major city of
eastern Golestan, which has permitted, for the first time in this region, endoscopic localisation and histologic examination of upper GI
cancers. Among the initial 682 patients seen at Atrak Clinic, 370 were confirmed histologically to have cancer, including 223 (60%)
oesophageal squamous cell cancers (ESCC), 22 (6%) oesophageal adenocarcinomas (EAC), 58 (16%) gastric cardia adenocarcinomas
(GCA), and 58 (16%) gastric noncardia adenocarcinomas. The proportional occurrence of these four main site-cell type subdivisions
of upper GI cancers in Golestan is similar to that seen in Linxian, China, another area of high ESCC incidence, and is markedly
different from the current proportions in many Western countries. Questioning of patients about exposure to some known and
suspected risk factors for squamous cell oesophageal cancer confirmed a negligible history of consumption of alcohol, little use of
cigarettes or nass (tobacco, lime and ash), and a low intake of opium, suggesting that the high rates of ESCC seen in northeastern Iran
must have other important risk factors that remain speculative or unknown. Further studies are needed to define more precisely the
patterns of upper GI cancer incidence, to test other previously suspected risk factors, and to find new significant risk factors in this
high-risk area.
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A cancer registry maintained by the International Agency for
Research on Cancer (IARC) and the Institute of Public Health
Research of Tehran University (IPHR) showed that from June 1968
to June 1971 the age-adjusted incidence rates of oesophageal
cancer (EC) for both men and women from Golestan Province who
lived in the steppe grasslands of the Turkmen plain and
neighbouring hills in the north-eastern part of the province were
higher than 100/100000 and thus among the highest rates in the
world (Kmet and Mahboubi, 1972; Mahboubi et al, 1973).
Moreover, whereas in Western countries EC has been mainly a
disease of men who smoke and drink alcohol heavily (Munoz and
Day, 1996; Brown et al, 2001), in the very high incidence areas of
Golestan Province (inhabited almost entirely by Turkmens) there
were very low rates of smoking and drinking and EC was slightly
more common in women than in men. The cancer registry also
showed sharp gradients of incidence over relatively short
geographical distances. Rates fell westward for some 300km along
the southern Caspian littoral (a densely populated area inhabited
largely by Persians) through Mazandaran Province and into Gilan
Province (a much wetter region of rice paddies and orange groves)
where the incidence was lower than 10 per 100000 in women and
between 10 and 20 per 100000 for men.
Ecological and nutritional studies conducted by IARC and IPHR
to establish the epidemiologic features and to investigate the
aetiology of EC throughout the Caspian Littoral including Golestan
Province (Joint Iran-IARC Cancer Study Group, 1977) found
geographical associations of incidence with a number of variables.
A subsequent case–control study investigated these associations
further and established some risk factors, especially poverty and a
restricted diet very low in fresh fruit and vegetables (Cook-
Mozaffari et al, 1979), factors that have since been shown to be
associated with an elevated risk for oesophageal cancer in almost
all countries where diet has been studied (Munoz and Day, 1996),
but it found no clear evidence for other potential risk factors such
as hot tea or nass consumption. However, the studies in Iran were
discontinued due to the sociopolitical changes there in 1979,
before the complete patterns of incidence and the full complement
of risk factor results could be established. Some of the major
questions that were left unanswered were the precise incidence of
EC and GC and the proportions of different histologic subtypes of
oesophageal tumours in the different ethnicities in Golestan
Province, partly because population data by ethnic group were
not available and partly because the lack of endoscopy and
histological diagnoses may have led to incorrect designation of
tumour location and histology for a proportion of patients. It was
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ypostulated at the time that almost all the oesophageal cancer cases
in this area were of squamous origin, but 98% of the tumours were
diagnosed by radiology or by clinical methods alone and only 2%
had histological confirmation (Mahboubi et al, 1973).
In August 2001, we opened a referral clinic for upper
gastrointestinal (GI) tract cancers, the Atrak Clinic, in the principal
city of the region, Gonbad, at the Khatam hospital, the largest
hospital of eastern Golestan. The Clinic is affiliated with and
staffed by the Digestive Disease Research Centre (DDRC) of
Tehran University of Medical Sciences. Our aims were both to
provide care for patients and to build on the previously unfinished
research studies. Here, we report on the patients seen in the first 24
months of Atrak Clinic, including the location and histology of the
oesophageal and gastric cancers and some epidemiological features
of these cancer cases. We also compare our findings with those of
the previous studies in Iran and with the epidemiological features
of GI cancers seen in Linxian, China, another area with extremely
high rates of EC.
MATERIALS AND METHODS
The majority of cancer patients in eastern Golestan present first to
the local general practitioners or to the medical and surgical
specialists in the area, and only a small group of patients are first
diagnosed in major cities outside the area. Before the study began,
the investigators contacted all of the local medical practitioners
and asked them to refer their patients with suspected GI tract
cancers to the Atrak Clinic. From August 2001 to August 2003, 682
patients were referred to the Atrak Clinic. Based on the results of a
recent cancer surveillance study and an ongoing cancer registra-
tion in Golestan Province, we have shown that approximately 70%
of the incident cases of oesophageal cancer recorded in the eastern
part of Golestan Province during the study period were referred to
the Clinic (unpublished data), so the results of this report may be
generalised to represent the experience of eastern Golestan
Province.
All the 682 patients referred to the Atrak Clinic were suspected
of having upper GI cancers. After signing an informed consent, the
patients were interviewed by a physician using a structured
questionnaire and underwent physical examination followed by
oesophago-gastro-duodenal videoendoscopy. Intravenous Mida-
zolam (5mg) and 10% lidocaine spray to the pharynx were used as
premedication. Local medical specialists, who had been given
specific training, performed the endoscopies using Olympus GIF-
XQ230 and Pentax EG-2900 video endoscopes. At least four
biopsies were obtained from all of the tumours that were found
during endoscopy and standard biopsies were taken from the
antrum, the gastric body (lesser curvature), the cardia and the
oesophagus in all patients. Two more biopsies were taken from
columnar-lined distal oesophagus, if such tissue existed. The
endoscopic data were entered on predesigned forms, and the
location of the tumours was either captured and registered
electronically (90% of the tumours), or precisely drawn on a
specially designed form. An experienced endoscopist (R Malekza-
deh) reviewed both the endoscopic reports and the captured
images to confirm the exact site of the tumours. Biopsy specimens
were oriented and spread on strips of filter paper and fixed
immediately in 10% buffered formalin. The samples were sent to
the DDRC, in Tehran, where they were embedded, sectioned and
stained with haematoxylin and eosin and examined by experienced
DDRC pathologists (M Sotoudeh and B Abedi).
The cancers were classified into four groups: oesophageal
squamous cell carcinoma (ESCC), oesophageal adenocarcinoma
(EAC), gastric cardia adenocarcinoma (GCA) and gastric non-
cardia adenocarcinoma (GNCA). Adenocarcinomas of the stomach
were classified as intestinal or diffuse type using Lauren’s
classification criteria (Lauren, 1965). Gastric cardia tumours were
defined as adenocarcinoma with an estimated point of origin
within 1cm proximal or 3cm distal of the oesophago-gastric
junction.
The study was reviewed and approved by the Institutional
Review Boards of the DDRC and the US National Cancer Institute.
RESULTS
Among the initial 682 patients, 398 were suspected at endoscopy of
having upper GI tract cancer and 370 subsequently had histological
confirmation of malignancy. Table 1 summarises the sites and the
histological diagnoses found in these 370 patients. ESCC was the
most common type of cancer seen at the Atrak Clinic, constituting
91% of all oesophageal cancers and 60% of all upper GI cancers.
The middle third of the oesophagus was the most frequent site of
origin of these tumours: 32 (13%) of all oesophageal tumours were
found in the upper third, 135 (54%) in the middle third, and 82
(33%) in the lower third. EAC was relatively uncommon,
comprising only 9% of all oesophageal cancers and 6% of all
upper GI cancers. The gastric cancers were evenly split between
GCA and GNCA. Among patients diagnosed with gastric
adenocarcinoma, the intestinal type of cancer was approximately
twice as frequent as the diffuse type.
Table 2 summarises the demographic characteristics of the 361
cancer patients diagnosed with ESCC, EAC, GCA or GNCA, and of
the 284 patients with no endoscopically suspicious lesion
(noncancer patients). Median age was close to 65 years in cancer
patients and 60 in the noncancer patients. The male to female ratio
was close to 1:1 in ESCC, EAC patients and noncancer patients
and close to 3:1 in GCA and GNCA patients. In all, 31% of the
ESCC, EAC, and GCA patients, 40% of the GNCA patients and 45%
of the noncancer patients were from urban areas. There were no
significant differences in the proportion of urban residence among
the first three cancer groups. A higher proportion of ESCC, EAC
and GCA, but not GNCA patients, were from rural areas compared
with the noncancer patients (w
2 12.9, Po0.001 and 0.65, P¼0.42,
respectively). Totally, 54% of ESCC, EAC and GCA patients, but
only 36% of GNCA and 32% of noncancer patients were Turkmens;
the proportions of Turkmens were significantly higher for both
Table 1 Site and histological diagnosis of the upper gastrointestinal
cancers in patients referred to the Atrak Clinic
Histological type Frequency
Oesophageal squamous cell carcinoma 223 (60%)
Oesophageal adenocarcinoma 22 (6%)
Intestinal type 11
Diffuse type 8
Not determined 3
Gastric cardia adenocarcinoma 58 (16%)
Intestinal type 35
Diffuse type 16
Not determined 7
Gastric noncardia adenocarcinoma 58 (16%)
Intestinal type 34
Diffuse type 17
Not determined 7
Others 9 (2%)
Oesophageal adenosquamous carcinoma 4
Gastric lymphoma 1
Duodenal adenocarcinoma 4
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yoesophageal and GCA patients, but not for GNCA patients, than
for noncancer patients (w
2 28.2 Po0.001 and 0.32 P¼0.57). There
were no significant differences in Turkmen ethnicity among the
ESCC, EAC and GCA groups (w
2 0.86 and P¼0.66).
Table 3 shows the prevalence of previous exposure to some
known or suspected risk factors for ESCC, including alcohol
consumption, cigarette smoking, the chewing of nass and opium
consumption. These data were available for only 238 cancer
patients and 260 noncancer patients. Only two (1%) of the cancer
patients and five (2%) of the noncancer patients had ever
consumed alcohol. In total, 29% of all cancer patients and 20%
of noncancer patients had ever smoked. Smoking was more
frequent among men: 39% of all male cancer patients and 12% of
all female cancer patients had ever smoked, with rates being very
similar across the cancer groups. Nass was used by 14% of cancer
patients and 9% of noncancer patients, and opium consumption
was seen in 37% of all cancer patients and 29% of noncancer
patients. To investigate whether opium consumption was an old
habit or it was used as a medication to alleviate pain from a recent
disease, we asked the patients about the time they had started
using opium. Those who had started in the year prior to being
referred to Atrak Clinic were classified as new users. In all, 27% of
ESCC patients had started their opium use earlier than 1 year ago,
and 6% had started in the year before being referred to the Atrak
Clinic. Taken together, 50% of all cancer patients and 39% of
noncancer patients had ever used at least one of these risk factors.
DISCUSSION
In total, 245 cases of oesophageal cancer and 116 cases of gastric
cancer were referred to the Atrak Clinic in the first 24 months after
it was opened. Assuming that the proportion of UGI cancer cases
referred to the clinic was independent of tumour site, we can
conclude that EC is approximately twice as common as GC in
eastern Golestan Province. In addition, almost half of the GC cases
occurred in the cardia of the stomach. A predominance of EC cases
over GC cases and a large number of GC cases originating in the
cardia are common findings in populations at high risk for EC, but
are unusual findings for other areas of the world. For example in
Linxian, China, another area with very high rates of EC, the EC:GC
ratio is also greater than one and the GCA cases far outnumber the
cases of GNCA (Blot et al, 1993), but in most areas of the world, the
opposite proportions are found.
Compared to the cancer registry rates for 1969–1971 in this
area, which showed an EC:GC ratio of 8:1 (Mahboubi et al, 1973),
the current much lower 2:1 ratio might seem to imply that
changes in incidence have occurred for either or both sites in
eastern Golestan, but a substantial part of the difference may be an
artefact of diagnostic method and classification. ESCC, EAC and
GCA all usually present with dysphagia as the dominant symptom,
while GNCA usually presents with abdominal pain without
dysphagia. In the 1970s, when endoscopy was not available in
the region, ESCC, EAC and GCA were probably all diagnosed as
EC, while only GNCA was diagnosed as GC. Also supporting this
possibility is the observation that in the 1970s more than half of
the oesophageal cancers were located in the lower third (Mahboubi
et al, 1973), while in the present series only a third of these
tumours were localised to that site. This difference could be
explained by some of the cancers previously classified as lower
third oesophageal tumours now being more accurately classified as
GCA. If one combines the current figures for ESCC, EAC and GCA,
the EC:GC ratio is 5:1. Of course, some real changes in the
incidence of these tumours may also have occurred and some of
the changes may be due to differential levels of referral, but much
of the apparent change in their proportions appears to be due to
these changes in diagnostic method and classification.
ESCC is the dominant histological type of EC in eastern Golestan
Province, since more than 90% of the EC cases in this series were
ESCC. This predominance of ESCC:EAC is also seen in other high-
risk EC populations, but is not as common in populations with low
EC risk. In Linxian, for example, virtually all EC cases are ESCC,
but in the US, the proportion of EAC cases among all oesophageal
cancer cases has increased from 14 to 51% from 1975 to 1998, and
intestinal type EAC is now the predominant histological type
(Polednak, 2003). Similar sharp increases in incidence of EAC have
Table 2 Demographic characteristics of cancer and noncancer patients referred to the Atrak Clinic
Characteristic
Oesophageal cancer Gastric cancer Patients with no
endoscopically
suspicious lesion
(n¼284)
Squamous cell
carcinoma (n¼223)
Adenocarcinoma
(n¼22) Cardia (n¼58) Noncardia (n¼58)
Median age (interquartile
range)
65 (55–72) 66 (58–74) 66 (57–73) 64 (59–72) 60 (47–69)
Sex (male) 116 (52%) 13 (59%) 42 (72%) 44 (76%) 154 (54%)
Residence (urban) 70 (31%) 7 (32%) 17 (29%) 23 (40%) 129 (45%)
Ethnicity (Turkmen) 119 (53%) 14 (64%) 31 (53%) 21 (36%) 92 (32%)
Table 3 Prevalence of some suggested oesophageal cancer risk factors in patients referred to the Atrak Clinic
Characteristic
Oesophageal cancer Gastric cancer Patients with no
endoscopically
suspicious lesion
(n¼260)
Squamous cell
carcinoma (n¼144)
Adenocarcinoma
(n¼12) Cardia (n¼42) Noncardia (n¼40)
Alcohol (ever consumed) 1 (1%) 1 (10%) 0 (0%) 0 (0%) 5 (2%)
Smoking (ever smoked) 39 (27%) 3 (25%) 14 (33%) 12 (30%) 51 (20%)
Nass (ever used) 18 (12%) 3 (25%) 6 (14%) 6 (15%) 23 (9%)
Opium
a
New users 9 (6%) 0 (0%) 4 (10%) 6 (15%) 15 (6%)
Old users 39 (27%) 4 (33%) 11 (26%) 14 (35%) 56 (22%)
Any risk factor
b 69 (48%) 5 (42%) 23 (55%) 22 (55%) 102 (39%)
aNew user refers to those who started opium use during the year before the diagnosis was made. Old user refers to those started opium use earlier than 1 year before the
diagnosis.
bAny risk factor refers to using at least one of the four risk factors (alcohol, cigarette, nass or opium).
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yalso been reported from Europe (Walther et al, 2001; Powell et al,
2002), but no such trend has been observed in Golestan Province.
In this series, intestinal-type tumours were the predominant type
of adenocarcinomas, being twice as frequent as the diffuse-type
tumours. This pattern and strong male predominance for gastric
carcinomas in Golestan are similar to the patterns observed in
other high-incidence rate areas of the world (Nomura, 1996).
ESCC was equally distributed between the two sexes, similar to
the ratio in Linxian, but completely different from the pattern seen
in Western countries, where the incidence of ESCC is low but is
several-fold higher in men than in women (Munoz and Day, 1996).
The proportion of ESCC, EAC and GCA cases who were from
rural areas or were of Turkmen ethnicity were similar and were
higher than the proportions of these characteristics among GNCA
or noncancer patients. Finding characteristics in which GCA
patients are more similar to oesophageal cancer patients than to
GNCA patients is also common in Linxian (Blot et al, 1993; Mark
et al, 2000; Taylor et al, 2003).
Only one of the 144 ESCC cases had ever consumed alcohol, so
alcohol cannot be considered a risk factor for ESCC in Golestan
Province. It also appears that smoking is not a predominant risk
factor. Only 27% of ESCC patients had ever smoked, and this
proportion was similar to the proportion of smokers in the other
cancer groups and noncancer patients. In addition, despite higher
rates of smoking among men in Golestan (10.4% in men vs 0.4% in
women in a large survey of the general population in this area
(Noorbala and Mohammad, 1999)), ESCC incidence rates in this
region are similar in men and women. A similar situation has been
reported in Linxian, where smoking is much more common in
men, the ESCC rates are similar in men and women, and the
relative risk of ESCC associated with smoking is 1.6 (Guo et al,
1994; Abnet et al, 2001), making only 15% of the ESCC cases
attributable to smoking. A totally different pattern is seen in
Western countries: approximately 92% of all ESCC cases in the US
have been attributed to smoking and alcohol consumption (Brown
et al, 2001). However, it should be noted that most of the cases in
most Western studies are men, and a recent study confined to
women in the UK showed no association with alcohol and only a
slight elevation of risk associated with smoking (Sharp et al, 2001).
Nass chewing, another locally suspected risk factor for ESCC,
was seen in 12% of ESCC cases (18% of male and 6% of female
patients), similar to the rates in the other cancer groups and in
noncancer patients. The findings for the chewing of nass are in
keeping with the results of the earlier case–control study which
showed no elevation of risk for nass consumption (Cook-Mozaffari
et al, 1979).
The consumption of opium, and in particular of opium dross
(shireh and sukhteh), has been suspected to be a major aetiological
factor for ESCC in Golestan Province (Joint Iran-IARC Study
Group, 1977; Hewer et al, 1978; Malaveille et al, 1982; Dowlatshahi
and Miller, 1985; Ghadirian et al, 1985). One-third (33%) of ESCC
patients in our study had ever used opium, and similar
proportions of opium usage were seen in the other patients. In
order to evaluate the validity of such questionnaire responses
concerning opium use among our patients, we recently measured
opium metabolites in urines of 150 Golestan adults who responded
to a similar questionnaire, evenly divided between those who
admitted using opium and those who did not. Opium consumption
reported by questionnaire was found to have a sensitivity and
specificity of 90 and 91%, respectively, compared to urine
results (Abnet et al., in press). So we think the questionnaire is
reasonably valid. In the 1970s, however, almost half of the
population tested from the high incidence areas had levels of
morphine metabolites in the urine (Ghadirian et al, 1985; Munoz
and Day, 1996), so there may have been a reduction of intake over
the past 20 years. The role of opium and opium dross as
aetiological factors for ESCC still needs further in-depth epide-
miological investigation in this region, as does the role of hot tea,
for which the earlier results were suggestive but equivocal (Cook-
Mozaffari et al, 1979; Ghadirian, 1987). Hot drinks and stews have
since been associated with elevated risk in other parts of the world
(Munoz and Day, 1996).
The studies that were conducted in the 1970s in the Caspian
Littoral and Golestan Province showed that areas inhabited by
Turkmens had a much higher incidence rate of EC than areas with
mainly Persian population, although the differences were less
marked within Golestan Province (Kmet and Mahboubi, 1972;
Mahboubi et al, 1973). In our study, approximately 50% of ESCC
cases and other cancers were Turkmen patients. Based on the
reports from the Iranian Ministry of Health, 51% of the population
in Gonbad, Minoodasht and Kalaleh, the major city and towns
referring patients to Atrak Clinic, are Turkmens. We are not sure
that the percentage of Turkmen and non-Turkmen cancer patients
referred to our clinic is the same, but if our ESCC patients are
representative of all the ESCC patients in the area, then the risk of
ESCC in Turkmens and non-Turkmens in this area is equal. If 70%
of the incident cases of oesophageal cancer in eastern part of
Golestan Province have been referred to the Atrak Clinic (as
indicated by the interim results of the cancer registry) and if all the
patients who have not been referred to our clinic were Turkmens,
the risk of ESCC in Turkmens would be 1.99 that of the risk in
non-Turkmens. This analysis argues against the existence of strong
Turkmen-specific genetic components in the aetiology of ESCC in
eastern Golestan. Only two (1%) of the ESCC cases were younger
than 30 years of age and eight (4%) were younger than 40 years of
age, another finding that argues against genetic factors being the
predominant aetiological factors.
In summary, the results of this study show that ESCC is still the
predominant type of upper GI cancer in high-risk areas of
Golestan Province, and that tobacco, nass, alcohol and perhaps
opium consumption are not the major aetiological factors for
ESCC in this area. ESCC seems to be distributed among both
Turkmens and non-Turkmens, and among both city and village
dwellers. Therefore, it is likely that the main aetiologic factors for
high incidence of ESCC are factors that are shared by most
inhabitants of this area. Further case–control and cohort studies
are needed to explore the risk factors associated in this region with
the very high rates of ESCC.
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